Michael Peel has been science editor of the Financial Times since October 2023. He covers all elements of science, from the sub-microscopic to the cosmic.
Michael is a chemistry graduate and has been an FT journalist for more than 25 years, including postings in Lagos, Abu Dhabi, Bangkok and Brussels. He has been seconded in Tokyo as executive editor of Nikkei Asia. He is the author of The Fabulists: How Myth-makers Rule in an Age of Crisis (Paperback 2021) and A Swamp Full of Dollars: Pipelines and Paramilitaries at Nigeria’s Oil Frontier (2009), which was shortlisted for the Guardian First Book Award.
New compound increases strength of antidote for fentanyl and other lethal drugs
More detail and less ‘soundbites’ needed to unlock the sector’s economic potential, say science and tech groups
Discovery could allow more precise and efficient targeting of DNA modifications
Oral formulation offers prospect of cheaper and more convenient access to drug, research suggests
Research estimates how much the fast-evolving technology hits various jobs, from software engineers to mechanics
Researchers are trying to tackle the threat before nature’s ‘flying needles’ become more prevalent and resistant to prevention
Innovation prize targeting urinary tract infections boosts effort to tackle pathogens that develop immunity to drugs
Alcohol, food, tobacco and fossil fuel sectors oppose efforts to target conditions linked to 2.7mn deaths a year, warns WHO
‘Gene desert’ research boosts knowledge of chronic disease mechanisms and promises to unlock novel therapies
Annual list topped by Massachusetts Institute of Technology and Imperial College London
‘Nuclear transmutation’ could cut highly radioactive waste by 80%, says national body
Karim Khan’s bid for arrest warrants is pivotal moment for international court
‘Reasonable grounds’ to believe that five individuals including Benjamin Netanyahu committed war crimes, prosecutor Karim Khan says
Bloc tells London it will be locked out of Iter project in France within months unless it rejoins civil atomic programme
AlphaFold 3 aims to reveal biological secrets and boost drug search efforts
Novo Nordisk, Bill & Melinda Gates Foundation and Wellcome focus on interlinked issues
Experts warn better data is required to drive policy as debilitating condition reduces workforce
Shadow science minister Chi Onwurah pledges more collaborative approach and greater respect for institutions
While pandemic risk is low, scientists say urgent investigations into the virus are necessary
Caseloads of cancer and other illnesses of ageing are forecast to rise steeply in lower income countries
Wellcome’s John-Arne Røttingen says divisions risk harming action on pandemic responses and ‘superbugs’
A battalion of troops remains in the tiny petrostate
Global warming, flooding and pollution could all help promote evolution of pathogens
Technique devised for Timothy syndrome could open way to therapies for other untreatable conditions
Technique highlights concerns shifting global disease burden as populations age
International Edition